Invesco Ltd.
NYSE:IVZAsset Management
-$0.41 today
- Market cap
- $12.59B
- Beta
- 1.59
- P/E (TTM)
- -53.4
- EPS (TTM)
- -$0.54
- Dividend yield
- 2.94%
Volume 5.54M
Average 5.41M
IVZ Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
Invesco Ltd.NYSE: IVZ
Revenue · Q2 FY2026 · quarter ended Jun 2026
Revenue growth accelerates
Q2 FY2026 revenue of $1.83B rose 20.5% year over year, ahead of the +12.2% change in trailing-twelve-month revenue. Sequentially, it rose 4.6% from the prior quarter. Over 3 fiscal years it compounded at +1.8% a year.
Context
- Revenue increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether revenue reaches the consensus estimate from 4 analysts of $5.37B (-15.8%) for the fiscal year ending Dec 2026, a slowdown from the +5.1% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $1.83B+4.6% QoQ
- Last fiscal yearDec 2025
- $6.38B+5.1% YoY
- LTMJun 2026
- $6.9B+12.2% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +20.5% | -15.7% | -36.1 pp |
| 1 year | +5.1% | -15.8% | -20.9 pp |
| 3-year CAGR | +1.8% | -1.0% | -2.8 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 6.38B USD
- Year-over-year change
- +5.1%
- 4-year CAGR
- -1.9%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.38B | +5.1% |
| FY2024 | 2024-12-31 | 6.07B | +6.1% |
| FY2023 | 2023-12-31 | 5.72B | -5.5% |
| FY2022 | 2022-12-31 | 6.05B | -12.3% |
| FY2021 | 2021-12-31 | 6.89B | — |
Revenue vs competitors
How IVZ compares with its peers on the latest reported figures
- IVZ's LTM Jun 2026 revenue of $6.9B is the 5th highest of the 11 companies compared; the peer median is $2.57B.
- Its year-over-year change of +12.2% is the 3rd highest of 11, against a peer median of +7.5%.
- Over three fiscal years its annual growth of +1.8% compares with a peer median of +5.5%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jun 2026 | $19.82B | +8.8% | +9.7% | |
| LTM Jun 2026 | $15.69B | +3.7% | -3.8% | |
| LTM Jun 2026 | $9.32B | +7.9% | +6.3% | |
| LTM Jun 2026 | $7.59B | +7.0% | +4.1% | |
| LTM Jun 2026 | $6.9B | +12.2% | +1.8% | |
| LTM Sep 2026 | $2.6B | +27.1% | +1.6% | |
| LTM Sep 2026 | $2.54B | +12.9% | +4.9% | |
| LTM Sep 2026 | $1.26B | +8.7% | +6.4% | |
| LTM Jun 2026 | $343.43M | -17.2% | +2.9% | |
| LTM Mar 2026 | $99.48M | +4.4% | +12.5% | |
| LTM Mar 2026 | $33.01M | -7.1% | +6.2% | |
| Peer median (excluding IVZ) | $2.57B | +7.5% | +5.5% | |
Competitors are the stored peer set for IVZ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 6.89B | 6.05B | 5.72B | 6.07B | 6.38B |
| Cost of Revenue | 4.06B | 3.61B | 3.71B | 4.04B | 3.62B |
| Gross Profit | 2.83B | 2.44B | 2.01B | 2.03B | 2.75B |
| Gross Margin | 41.1% | 40.3% | 35.1% | 33.4% | 43.2% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 522.7M | 588.2M | 649.7M | 676M | 660.5M |
| Operating Expenses | 1.05B | 1.12B | 2.44B | 1.2B | 3.45B |
| Depreciation & Amortization | 205.3M | 195.3M | 182.8M | 179.6M | 155.9M |
| EBITDA | 2.8B | 1.53B | 15.4M | 1.24B | (390.8M) |
| EBITDA Margin | 40.6% | 25.3% | 0.3% | 20.5% | -6.1% |
| Operating Income | 1.79B | 1.32B | (434.8M) | 832.1M | (695.7M) |
| Operating Margin | 25.9% | 21.8% | -7.6% | 13.7% | -10.9% |
| Interest Income | 25.2M | 24.4M | 47.8M | 58.9M | 53.9M |
| Interest Expense | 94.7M | 85.2M | 70.5M | 58M | 82.5M |
| Other Income / Expenses | 712.3M | (70M) | 196.9M | 173.2M | 316.3M |
| Income Before Tax | 2.5B | 1.25B | (237.9M) | 1.01B | (379.4M) |
| Pre-Tax Margin | 36.3% | 20.6% | -4.2% | 16.6% | -5.9% |
| Income Tax Expense | 531.1M | 322.2M | (69.7M) | 252.9M | (204.6M) |
| Net Income | 1.63B | 920.7M | (96.9M) | 774.8M | (281.7M) |
| Net Margin | 23.6% | 15.2% | -1.7% | 12.8% | -4.4% |
| EPS (Basic) | 3.01 | 1.50 | (0.73) | 1.18 | (1.61) |
| EPS (Diluted) | 2.99 | 1.49 | (0.73) | 1.18 | (1.60) |
| Weighted Avg Shares | 462.8M | 457.5M | 454.8M | 457M | 451.2M |
| Weighted Avg Shares (Diluted) | 465.4M | 459.5M | 456.2M | 457.7M | 453.8M |
Invesco Ltd.
NYSE:IVZ
Intrinsic Alpha fair value
Locked
Current Price
$28.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.